Literature DB >> 20302384

Self-assembly behavior of colistin and its prodrug colistin methanesulfonate: implications for solution stability and solubilization.

Stephanie J Wallace1, Jian Li, Roger L Nation, Richard J Prankerd, Tony Velkov, Ben J Boyd.   

Abstract

Colistin is an amphiphilic antibiotic that has re-emerged into clinical use due to the increasing prevalence of difficult-to-treat Gram-negative infections. The existence of self-assembling colloids in solutions of colistin and its derivative prodrug, colistin methanesulfonate (CMS), was investigated. Colistin and CMS reduced the air-water interfacial tension, and dynamic light scattering (DLS) studies showed the existence of 2.07 +/- 0.3 nm aggregates above 1.5 mM for colistin and of 1.98 +/- 0.36 nm aggregates for CMS above 3.5 mM (mean +/- SD). Above the respective critical micelle concentrations (CMC) the solubility of azithromycin, a hydrophobic antibiotic, increased approximately linearly with increasing surfactant concentration (5:1 mol ratio colistin:azithromycin), suggestive of hydrophobic domains within the micellar cores. Rapid conversion of CMS to colistin occurred below the CMC (60% over 48 h), while conversion above the CMC was less than 1%. The formation of colistin and CMS micelles demonstrated in this study is the proposed mechanism for solubilization of azithromycin and the concentration-dependent stability of CMS.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20302384      PMCID: PMC2881163          DOI: 10.1021/jp100458x

Source DB:  PubMed          Journal:  J Phys Chem B        ISSN: 1520-5207            Impact factor:   2.991


  32 in total

1.  A simple method for the assay of colistin in human plasma, using pre-column derivatization with 9-fluorenylmethyl chloroformate in solid-phase extraction cartridges and reversed-phase high-performance liquid chromatography.

Authors:  J Li; R W Milne; R L Nation; J D Turnidge; K Coulthard; D W Johnson
Journal:  J Chromatogr B Biomed Sci Appl       Date:  2001-09-25

2.  Trends in antimicrobial drug development: implications for the future.

Authors:  Brad Spellberg; John H Powers; Eric P Brass; Loren G Miller; John E Edwards
Journal:  Clin Infect Dis       Date:  2004-04-14       Impact factor: 9.079

3.  Solubilization of monovalent weak electrolytes by micellization or complexation.

Authors:  Yan He; Samuel H Yalkowsky
Journal:  Int J Pharm       Date:  2006-03-31       Impact factor: 5.875

4.  Compounded colistimethate as possible cause of fatal acute respiratory distress syndrome.

Authors:  Karen S McCoy
Journal:  N Engl J Med       Date:  2007-11-29       Impact factor: 91.245

Review 5.  Antibiotic resistance: the perfect storm.

Authors:  I M Gould
Journal:  Int J Antimicrob Agents       Date:  2009-08       Impact factor: 5.283

6.  Liposomal (MLV) polymyxin B: physicochemical characterization and effect of surface charge and drug association.

Authors:  S M Lawrence; H O Alpar; S M McAllister; M R Brown
Journal:  J Drug Target       Date:  1993       Impact factor: 5.121

7.  Comparison of the structure and dynamics of the antibiotic peptide polymyxin B and the inactive nonapeptide in aqueous trifluoroethanol by NMR spectroscopy.

Authors:  Jeffrey J Meredith; Antoine Dufour; Martha D Bruch
Journal:  J Phys Chem B       Date:  2009-01-15       Impact factor: 2.991

8.  Self-assembled cylindrical and vesicular molecular templates for polyaniline nanofibers and nanotapes.

Authors:  P Anilkumar; M Jayakannan
Journal:  J Phys Chem B       Date:  2009-08-27       Impact factor: 2.991

9.  Outer membrane permeability barrier to azithromycin, clarithromycin, and roxithromycin in gram-negative enteric bacteria.

Authors:  M Vaara
Journal:  Antimicrob Agents Chemother       Date:  1993-02       Impact factor: 5.191

10.  Self-association of analgesics in aqueous solution: micellar properties of dextropropoxyphene hydrochloride and methadone hydrochloride.

Authors:  D Attwood; J A Tolley
Journal:  J Pharm Pharmacol       Date:  1980-08       Impact factor: 3.765

View more
  17 in total

1.  Understanding the Impacts of Surface Compositions on the In-Vitro Dissolution and Aerosolization of Co-Spray-Dried Composite Powder Formulations for Inhalation.

Authors:  Sharad Mangal; Rongkun Xu; Heejun Park; Dmitry Zemlyanov; Nivedita Shetty; Yu-Wei Lin; David Morton; Hak-Kim Chan; Jian Li; Qi Tony Zhou
Journal:  Pharm Res       Date:  2018-11-07       Impact factor: 4.200

2.  Interaction of colistin and colistin methanesulfonate with liposomes: colloidal aspects and implications for formulation.

Authors:  Stephanie J Wallace; Jian Li; Roger L Nation; Richard J Prankerd; Ben J Boyd
Journal:  J Pharm Sci       Date:  2012-05-23       Impact factor: 3.534

Review 3.  Intrathecal Antibacterial and Antifungal Therapies.

Authors:  Roland Nau; Claudia Blei; Helmut Eiffert
Journal:  Clin Microbiol Rev       Date:  2020-04-29       Impact factor: 26.132

4.  Improved Physical Stability and Aerosolization of Inhalable Amorphous Ciprofloxacin Powder Formulations by Incorporating Synergistic Colistin.

Authors:  Nivedita Shetty; Patricia Ahn; Heejun Park; Sonal Bhujbal; Dmitry Zemlyanov; Alex Cavallaro; Sharad Mangal; Jian Li; Qi Tony Zhou
Journal:  Mol Pharm       Date:  2018-08-03       Impact factor: 4.939

Review 5.  Clinical Pharmacokinetics and Pharmacodynamics of Colistin.

Authors:  Nicolas Grégoire; Vincent Aranzana-Climent; Sophie Magréault; Sandrine Marchand; William Couet
Journal:  Clin Pharmacokinet       Date:  2017-12       Impact factor: 6.447

6.  Investigation of the Changes in Aerosolization Behavior Between the Jet-Milled and Spray-Dried Colistin Powders Through Surface Energy Characterization.

Authors:  Teresa Jong; Jian Li; David A V Morton; Qi Tony Zhou; Ian Larson
Journal:  J Pharm Sci       Date:  2016-01-30       Impact factor: 3.534

7.  Composite particle formulations of colistin and meropenem with improved in-vitro bacterial killing and aerosolization for inhalation.

Authors:  Sharad Mangal; Heejun Park; Lingfei Zeng; Heidi H Yu; Yu-Wei Lin; Tony Velkov; John A Denman; Dmitry Zemlyanov; Jian Li; Qi Tony Zhou
Journal:  Int J Pharm       Date:  2018-07-03       Impact factor: 5.875

8.  Drug release from nanomedicines: Selection of appropriate encapsulation and release methodology.

Authors:  Stephanie J Wallace; Jian Li; Roger L Nation; Ben J Boyd
Journal:  Drug Deliv Transl Res       Date:  2012-03-03       Impact factor: 4.617

9.  Structure-activity relationships for the binding of polymyxins with human α-1-acid glycoprotein.

Authors:  Mohammad A K Azad; Johnny X Huang; Matthew A Cooper; Kade D Roberts; Philip E Thompson; Roger L Nation; Jian Li; Tony Velkov
Journal:  Biochem Pharmacol       Date:  2012-05-12       Impact factor: 5.858

10.  Activities of colistin- and minocycline-based combinations against extensive drug resistant Acinetobacter baumannii isolates from intensive care unit patients.

Authors:  Wang Liang; Xiao-Fang Liu; Jun Huang; De-Mei Zhu; Jian Li; Jing Zhang
Journal:  BMC Infect Dis       Date:  2011-04-27       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.